As Abbott Labs Com (ABT) Share Value Rose, Pettyjohn Wood & White Has Cut by $307,230 Its Stake; As Genesis Energy LP (GEL) Market Value Declined, Kayne Anderson Capital Advisors LP Has Increased Its Position

April 23, 2018 - By Maria Brooks

Abbott Laboratories (NYSE:ABT) Logo

Pettyjohn Wood & White Inc decreased its stake in Abbott Labs Com (ABT) by 8.25% based on its latest 2017Q4 regulatory filing with the SEC. Pettyjohn Wood & White Inc sold 5,390 shares as the company’s stock rose 5.88% while stock markets declined. The institutional investor held 59,943 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $3.42M, down from 65,333 at the end of the previous reported quarter. Pettyjohn Wood & White Inc who had been investing in Abbott Labs Com for a number of months, seems to be less bullish one the $103.37B market cap company. The stock decreased 1.15% or $0.69 during the last trading session, reaching $59.19. About 5.87M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 23, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Kayne Anderson Capital Advisors Lp increased its stake in Genesis Energy LP (GEL) by 160.17% based on its latest 2017Q4 regulatory filing with the SEC. Kayne Anderson Capital Advisors Lp bought 571,814 shares as the company’s stock declined 14.68% with the market. The hedge fund held 928,814 shares of the energy company at the end of 2017Q4, valued at $20.76M, up from 357,000 at the end of the previous reported quarter. Kayne Anderson Capital Advisors Lp who had been investing in Genesis Energy LP for a number of months, seems to be bullish on the $2.60 billion market cap company. The stock increased 0.24% or $0.05 during the last trading session, reaching $21.24. About 352,403 shares traded. Genesis Energy, L.P. (NYSE:GEL) has declined 39.36% since April 23, 2017 and is downtrending. It has underperformed by 50.91% the S&P500.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. 24,408 are held by Drw Ltd Liability Corp. Freestone Capital Limited holds 0.18% or 45,384 shares in its portfolio. Allsquare Wealth Mngmt Limited Liability Corp has 850 shares for 0.04% of their portfolio. Moreover, Lincoln Natl Corporation has 0.09% invested in Abbott Laboratories (NYSE:ABT) for 52,215 shares. Putnam Invests Limited Liability Corp has invested 0% in Abbott Laboratories (NYSE:ABT). Private Advisor Group Inc Lc stated it has 0.27% of its portfolio in Abbott Laboratories (NYSE:ABT). Welch Group Lc, a Alabama-based fund reported 16,573 shares. Covington Invest Advisors owns 39,466 shares or 0.77% of their US portfolio. Badgley Phelps & Bell reported 14,473 shares. Healthcor Mngmt Limited Partnership holds 0.45% of its portfolio in Abbott Laboratories (NYSE:ABT) for 244,950 shares. Morgan Stanley reported 8.33 million shares. Alabama-based Andra Ap has invested 0.28% in Abbott Laboratories (NYSE:ABT). 3,621 are held by Capital Investment Services Of America. Private Ocean Limited Liability Company holds 0% in Abbott Laboratories (NYSE:ABT) or 22 shares. Pnc Fincl reported 5.59 million shares.

Since December 14, 2017, it had 1 buy, and 18 sales for $23.52 million activity. Funck Robert E had sold 1,220 shares worth $71,970 on Wednesday, February 28. Shares for $375,381 were sold by Contreras Jaime on Wednesday, February 28. On Wednesday, February 28 the insider MANNING JOSEPH J sold $84,344. The insider Blaser Brian J sold 27,733 shares worth $1.73M. $17,609 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Watkin Jared. 11,106 shares were sold by Fussell Stephen R, worth $667,804.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 106 analyst reports since July 24, 2015 according to SRatingsIntel. Edward Jones upgraded the shares of ABT in report on Tuesday, June 21 to “Buy” rating. The rating was upgraded by JP Morgan on Tuesday, January 2 to “Overweight”. The stock of Abbott Laboratories (NYSE:ABT) earned “Neutral” rating by Piper Jaffray on Thursday, April 28. The rating was maintained by Jefferies on Thursday, July 14 with “Buy”. The firm earned “Buy” rating on Tuesday, October 10 by Jefferies. The company was maintained on Saturday, August 29 by Deutsche Bank. The rating was maintained by RBC Capital Markets with “Buy” on Monday, October 2. The rating was maintained by Jefferies with “Buy” on Wednesday, October 18. Jefferies maintained the shares of ABT in report on Friday, June 16 with “Buy” rating. Guggenheim maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, January 25. Guggenheim has “Buy” rating and $72.0 target.

Investors sentiment increased to 1 in 2017 Q4. Its up 0.19, from 0.81 in 2017Q3. It is positive, as 20 investors sold GEL shares while 44 reduced holdings. 25 funds opened positions while 39 raised stakes. 87.56 million shares or 0.26% less from 87.79 million shares in 2017Q3 were reported. Rafferty Asset Management Limited Liability Corporation has 101,608 shares. Renaissance Tech Ltd reported 0% in Genesis Energy, L.P. (NYSE:GEL). Tarbox Family Office has 482 shares for 0% of their portfolio. Moreover, Cadence Capital Limited Liability Com has 0.17% invested in Genesis Energy, L.P. (NYSE:GEL). Toronto Dominion Comml Bank accumulated 65 shares or 0% of the stock. Moreover, Manufacturers Life Insur The has 0% invested in Genesis Energy, L.P. (NYSE:GEL). Stephens Inc Ar has 0.01% invested in Genesis Energy, L.P. (NYSE:GEL). Stratos Wealth Partners Ltd accumulated 0% or 648 shares. Mngmt Inc holds 2,600 shares or 0.02% of its portfolio. Goldman Sachs Gp owns 2.28M shares or 0.01% of their US portfolio. Ballentine Ptnrs Llc invested in 11,960 shares or 0.01% of the stock. Global X Co Llc owns 0.56% invested in Genesis Energy, L.P. (NYSE:GEL) for 1.10 million shares. Stifel Fincl invested 0.03% in Genesis Energy, L.P. (NYSE:GEL). Cutter & Brokerage Inc holds 9,966 shares. Clearbridge Invs Ltd Liability Com stated it has 0.2% of its portfolio in Genesis Energy, L.P. (NYSE:GEL).

Among 14 analysts covering Genesis Energy LP (NYSE:GEL), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. Genesis Energy LP had 42 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained Genesis Energy, L.P. (NYSE:GEL) on Friday, February 19 with “Outperform” rating. The rating was initiated by Janney Capital on Thursday, October 22 with “Buy”. The firm earned “Buy” rating on Friday, November 17 by Robert W. Baird. The firm earned “Underweight” rating on Tuesday, July 18 by Barclays Capital. The rating was downgraded by Wells Fargo on Friday, January 15 to “Market Perform”. The rating was maintained by Credit Suisse with “Outperform” on Friday, February 19. On Friday, February 17 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The rating was upgraded by Credit Suisse to “Outperform” on Monday, May 8. On Monday, August 7 the stock rating was upgraded by Robert W. Baird to “Outperform”. The rating was maintained by Citigroup on Thursday, August 4 with “Buy”.

Kayne Anderson Capital Advisors Lp, which manages about $18.02 billion and $7.84 billion US Long portfolio, decreased its stake in Hoegh Lng Partners Lp (NYSE:HMLP) by 304,483 shares to 1.78 million shares, valued at $33.28M in 2017Q4, according to the filing. It also reduced its holding in Transcanada Corp (NYSE:TRP) by 169,800 shares in the quarter, leaving it with 1.48 million shares, and cut its stake in Tallgrass Energy Gp Lp.

Since December 19, 2017, it had 2 insider buys, and 1 sale for $570,400 activity. $334,800 worth of stock was bought by JASTROW KENNETH M II on Tuesday, December 19. 700 shares were sold by Gaspard Garland G, worth $14,399.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Maria Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts